Literature DB >> 19098112

Glucosamine improves cardiac function following trauma-hemorrhage by increased protein O-GlcNAcylation and attenuation of NF-{kappa}B signaling.

Luyun Zou1, Shaolong Yang, Voraratt Champattanachai, Shunhua Hu, Irshad H Chaudry, Richard B Marchase, John C Chatham.   

Abstract

We have previously demonstrated that in a rat model of trauma-hemorrhage (T-H), glucosamine administration during resuscitation improved cardiac function, reduced circulating levels of inflammatory cytokines, and increased tissue levels of O-linked N-acetylglucosamine (O-GlcNAc) on proteins. The mechanism(s) by which glucosamine mediated its protective effect were not determined; therefore, the goal of this study was to test the hypothesis that glucosamine treatment attenuated the activation of the nuclear factor-kappaB (NF-kappaB) signaling pathway in the heart via an increase in protein O-GlcNAc levels. Fasted male rats were subjected to T-H by bleeding to a mean arterial blood pressure of 40 mmHg for 90 min followed by resuscitation. Glucosamine treatment during resuscitation significantly attenuated the T-H-induced increase in cardiac levels of TNF-alpha and IL-6 mRNA, IkappaB-alpha phosphorylation, NF-kappaB, NF-kappaB DNA binding activity, ICAM-1, and MPO activity. LPS (2 microg/ml) increased the levels of IkappaB-alpha phosphorylation, TNF-alpha, ICAM-1, and NF-kappaB in primary cultured cardiomyocytes, which was significantly attenuated by glucosamine treatment and overexpression of O-GlcNAc transferase; both interventions also significantly increased O-GlcNAc levels. In contrast, the transfection of neonatal rat ventricular myocytes with OGT small-interfering RNA decreased O-GlcNAc transferase and O-GlcNAc levels and enhanced the LPS-induced increase in IkappaB-alpha phosphorylation. Glucosamine treatment of macrophage cell line RAW 264.7 also increased O-GlcNAc levels and attenuated the LPS-induced activation of NF-kappaB. These results demonstrate that the modulation of O-GlcNAc levels alters the response of cardiomyocytes to the activation of the NF-kappaB pathway, which may contribute to the glucosamine-mediated improvement in cardiac function following hemorrhagic shock.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19098112      PMCID: PMC2643896          DOI: 10.1152/ajpheart.01025.2008

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  51 in total

Review 1.  O-GlcNAc: a regulatory post-translational modification.

Authors:  Lance Wells; Stephen A Whelan; Gerald W Hart
Journal:  Biochem Biophys Res Commun       Date:  2003-03-14       Impact factor: 3.575

2.  The aromatase inhibitor, 4-hydroxyandrostenedione, restores immune responses following trauma-hemorrhage in males and decreases mortality from subsequent sepsis.

Authors:  C P Schneider; E A Nickel; T S Samy; M G Schwacha; W G Cioffi; K I Bland; I H Chaudry
Journal:  Shock       Date:  2000-09       Impact factor: 3.454

3.  Capacitative calcium entry contributes to nuclear factor of activated T-cells nuclear translocation and hypertrophy in cardiomyocytes.

Authors:  Dacia L Hunton; Pamela A Lucchesi; Yi Pang; Xiaogang Cheng; Louis J Dell'Italia; Richard B Marchase
Journal:  J Biol Chem       Date:  2002-02-04       Impact factor: 5.157

4.  Flux through the hexosamine pathway is a determinant of nuclear factor kappaB- dependent promoter activation.

Authors:  Leighton R James; Damu Tang; Alistair Ingram; Hao Ly; Kerri Thai; Lu Cai; James W Scholey
Journal:  Diabetes       Date:  2002-04       Impact factor: 9.461

5.  Gender differences in the inflammatory response and survival following haemorrhage and subsequent sepsis.

Authors:  M D Diodato; M W Knöferl; M G Schwacha; K I Bland; I H Chaudry
Journal:  Cytokine       Date:  2001-05-07       Impact factor: 3.861

6.  Calpain inhibitor I reduces the activation of nuclear factor-kappaB and organ injury/dysfunction in hemorrhagic shock.

Authors:  M C McDonald; H Mota-Filipe; A Paul; S Cuzzocrea; M Abdelrahman; S Harwood; R Plevin; P K Chatterjee; M M Yaqoob; C Thiemermann
Journal:  FASEB J       Date:  2001-01       Impact factor: 5.191

7.  Hyperglycemia inhibits capacitative calcium entry and hypertrophy in neonatal cardiomyocytes.

Authors:  Yi Pang; Dacia L Hunton; Pam Bounelis; Richard B Marchase
Journal:  Diabetes       Date:  2002-12       Impact factor: 9.461

Review 8.  Effect of gender and sex hormones on immune responses following shock.

Authors:  M K Angele; M G Schwacha; A Ayala; I H Chaudry
Journal:  Shock       Date:  2000-08       Impact factor: 3.454

9.  O-GlcNAc modification is an endogenous inhibitor of the proteasome.

Authors:  Fengxue Zhang; Kaihong Su; Xiaoyong Yang; Damon B Bowe; Andrew J Paterson; Jeffrey E Kudlow
Journal:  Cell       Date:  2003-12-12       Impact factor: 41.582

Review 10.  Molecular mechanisms in the early phase of hemorrhagic shock.

Authors:  C Hierholzer; T R Billiar
Journal:  Langenbecks Arch Surg       Date:  2001-07       Impact factor: 3.445

View more
  68 in total

1.  O-linked beta-N-acetylglucosamine (O-GlcNAc) regulates stress-induced heat shock protein expression in a GSK-3beta-dependent manner.

Authors:  Zahra Kazemi; Hana Chang; Sarah Haserodt; Cathrine McKen; Natasha E Zachara
Journal:  J Biol Chem       Date:  2010-10-06       Impact factor: 5.157

Review 2.  The roles of O-linked β-N-acetylglucosamine in cardiovascular physiology and disease.

Authors:  Natasha E Zachara
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-01-27       Impact factor: 4.733

Review 3.  Phosphorylation mechanisms in intensive care medicine.

Authors:  Erica L Martin; V Marco Ranieri
Journal:  Intensive Care Med       Date:  2010-09-04       Impact factor: 17.440

4.  Protein O-GlcNAcylation: A critical regulator of the cellular response to stress.

Authors:  John C Chatham; Richard B Marchase
Journal:  Curr Signal Transduct Ther       Date:  2010-01

5.  Acute O-GlcNAcylation prevents inflammation-induced vascular dysfunction.

Authors:  Rob H P Hilgers; Dongqi Xing; Kaizheng Gong; Yiu-Fai Chen; John C Chatham; Suzanne Oparil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-07-09       Impact factor: 4.733

6.  O-GlcNAcylation, novel post-translational modification linking myocardial metabolism and cardiomyocyte circadian clock.

Authors:  David J Durgan; Betty M Pat; Boglarka Laczy; Jerry A Bradley; Ju-Yun Tsai; Maximiliano H Grenett; William F Ratcliffe; Rachel A Brewer; Jeevan Nagendran; Carolina Villegas-Montoya; Chenhang Zou; Luyun Zou; Russell L Johnson; Jason R B Dyck; Molly S Bray; Karen L Gamble; John C Chatham; Martin E Young
Journal:  J Biol Chem       Date:  2011-11-08       Impact factor: 5.157

7.  Macrophage exosomes as natural nanocarriers for protein delivery to inflamed brain.

Authors:  Dongfen Yuan; Yuling Zhao; William A Banks; Kristin M Bullock; Matthew Haney; Elena Batrakova; Alexander V Kabanov
Journal:  Biomaterials       Date:  2017-07-10       Impact factor: 12.479

Review 8.  O-GlcNAc and the cardiovascular system.

Authors:  Sujith Dassanayaka; Steven P Jones
Journal:  Pharmacol Ther       Date:  2013-11-25       Impact factor: 12.310

Review 9.  Functional O-GlcNAc modifications: implications in molecular regulation and pathophysiology.

Authors:  Krithika Vaidyanathan; Sean Durning; Lance Wells
Journal:  Crit Rev Biochem Mol Biol       Date:  2014-02-14       Impact factor: 8.250

10.  Increased O-linked beta-N-acetylglucosamine levels on proteins improves survival, reduces inflammation and organ damage 24 hours after trauma-hemorrhage in rats.

Authors:  Laszlo G Nöt; Charlye A Brocks; Laszlo Vámhidy; Richard B Marchase; John C Chatham
Journal:  Crit Care Med       Date:  2010-02       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.